Top Vaccines companies in Netherlands by Net Cash Used Provided By Financing Activities
Netherlands
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 1.34 B
|
Dec. 31, 2023 | USD 662.53 | -0.67% |
|
Netherlands |
|
| 2 |
USD 359.15 M
|
Dec. 31, 2023 | USD 17.60 | -0.73% |
|
Netherlands |
|
| 3 |
USD 230.09 M
|
Dec. 31, 2023 | USD 40.94 | -1.52% |
|
Netherlands |
|
| 4 |
USD 8.91 M
|
Dec. 31, 2023 | USD 22.29 | 2.39% |
|
Netherlands |
|
| 5 |
USD -571.00 K
|
Dec. 31, 2023 | USD 0.98 | -1.01% |
|
Netherlands |
Frequently Asked Questions
-
Which Vaccines company in Netherlands has the highest Net Cash Used Provided By Financing Activities ?
The Vaccines company in Netherlands with the highest Net Cash Used Provided By Financing Activities is argenx SE (Brussels Stock Exchange: ARGX.BR) at USD 1.34 B.
-
Which Vaccines company in Netherlands has the lowest Net Cash Used Provided By Financing Activities ?
The Vaccines company in Netherlands with the lowest Net Cash Used Provided By Financing Activities is LAVA Therapeutics N.V. (NasdaqGS: LVTX) at USD -571.00 K.
-
What are the top 10 Vaccines companies in Netherlands by Net Cash Used Provided By Financing Activities ?
The top 10 Vaccines companies in Netherlands by Net Cash Used Provided By Financing Activities are argenx SE, Pharvaris N.V., Merus N.V., NewAmsterdam Pharma Company N.V. and LAVA Therapeutics N.V..
-
What are the bottom 10 Vaccines companies in Netherlands by Net Cash Used Provided By Financing Activities ?
The bottom 10 Vaccines companies in Netherlands by Net Cash Used Provided By Financing Activities are LAVA Therapeutics N.V., NewAmsterdam Pharma Company N.V., Merus N.V., Pharvaris N.V. and argenx SE.
